# A Clinical Trial Evaluating the Efficacy and Safety of Sanhuang Jingshiming Pills in the Treatment of nAMD

> **NCT07269769** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Tasly Pharmaceutical Group Co., Ltd** · enrollment: 450 (estimated)

## Conditions studied

- AMD

## Interventions

- **DRUG:** Sanhuang Jingshiming/Pills placebo

## Key facts

- **NCT ID:** NCT07269769
- **Lead sponsor:** Tasly Pharmaceutical Group Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-30
- **Primary completion:** 2031-12-31
- **Final completion:** 2031-12-31
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07269769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07269769, "A Clinical Trial Evaluating the Efficacy and Safety of Sanhuang Jingshiming Pills in the Treatment of nAMD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07269769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*